Dallas, TX, May 04, 2016 --(PR.com
)-- An estimated 11.2 million hernia repair surgeries were performed globally in 2015 and this number is projected to reach approximately 12.6 million by 2022, growing at the rate of 1.7% during the forecasted years 2016 to 2022. The report includes inguinal, umbilical, femoral, incisional and other kinds of hernia such as hiatal hernia. Inguinal hernia is proven to be the most common form of hernia and constituted around 56.1% of the total number of hernia surgeries performed in the year 2015, followed by incisional or ventral hernia surgeries with 16.3%. Femoral hernia occurring are very rare and only forms 1.5% of all hernia surgeries in 2015. Hernia surgeries require closing or sealing the weak spot present in the muscle through which intestinal content is protruding out. Presently, there are two treatment options available – hernia repair surgeries using sutures and hernia repair using mesh.
North America dominate the market in terms of consumption of hernia repair mesh followed by Europe and APAC. In terms of revenue, North America holds 46.3% of the market in 2015, followed by Europe with 32.6% and APAC with 23.6%. APAC is expected to be the fastest growing market in the forecasted years due to huge number of hernia surgeries in India and China are still being operated using sutures and that scenario is expected to change due to better healthcare infrastructure and increasing awareness of minimally invasive surgeries in this region. The Global hernia mesh market is segmented into 2 mesh types Synthetic Mesh and Biologic Mesh. Synthetic mesh is the dominant product type in this market due to its affordability and incredible clinical acceptance from surgeons and the government. However, biologic mesh is quite new to the market, and is able to capture 6.2% of the market, in terms of volume in 2015. Due to the very expensive pricing of biologic meshes it holds almost 40% of the market in terms of value. The U.S. is the only country using biologic meshes very efficiently due the reimbursements being good and affordability not being an issue. The U.S. holds almost 58.0% of the biologic mesh market in terms of value in 2015.
The report further classifies Synthetic mesh into flat mesh and 3D mesh on the basis of structure of the mesh and into absorbable and non-absorbable based on the material the synthetic mesh is made of. Flat mesh is the most used mesh and accounts to more than 70% of the synthetic mesh segment in terms of market value. While the scenario of absorbable and non-absorbable synthetic meshes is varying from country to country based on the surgeons perspective in different geographies.
Some of the major players operating in this market are Medtronic, C.R. Bard, Inc., Atrium, W.L. Gore & Associates, Acelity and B Braun Melsungen AG among other players.
For free sample of the report
Mail at - firstname.lastname@example.org
Or visit - http://databridgemarketresearch.com/reports/global-hernia-mesh-devices-market/